Targeted Metabolomic Profiling of Peritoneal Dialysis Effluents Shows Anti-oxidative Capacity of Alanyl-Glutamine
Readily available peritoneal dialysis (PD) effluents from PD patients in the course of renal replacement therapy are a potentially rich source for molecular markers for predicting clinical outcome, monitoring the therapy, and therapeutic interventions. The complex clinical phenotype of PD patients m...
Main Authors: | Florian M. Wiesenhofer, Rebecca Herzog, Michael Boehm, Anja Wagner, Markus Unterwurzacher, David C. Kasper, Seth L. Alper, Andreas Vychytil, Christoph Aufricht, Klaus Kratochwill |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-01-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2018.01961/full |
Similar Items
-
Peritoneal Dialysis Fluid Supplementation with Alanyl-glutamine Attenuates Conventional Dialysis Fluid-mediated Endothelial Cell Injury by Restoring Perturbed Cytoprotective Responses
by: Rebecca Herzog, et al.
Published: (2020-12-01) -
The Peritoneal Surface Proteome in a Model of Chronic Peritoneal Dialysis Reveals Mechanisms of Membrane Damage and Preservation
by: Michael Boehm, et al.
Published: (2019-05-01) -
Alanyl-Glutamine Restores Tight Junction Organization after Disruption by a Conventional Peritoneal Dialysis Fluid
by: Maria Bartosova, et al.
Published: (2020-08-01) -
Oral administration of alanyl-glutamine and glutamine improve random pattern dorsal skin flap survival in rats
by: Mojtaba Karimpour, et al.
Published: (2018-08-01) -
Effects of alanyl-glutamine supplementation on the small intestinal mucosa barrier in weaned piglets
by: Shen Xing, et al.
Published: (2017-02-01)